LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 2 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 2. - Dataset (ID:20310)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Trametinib | 0.31623 | 48.36 | 17.25 | 52 | 4390 | 0.0118 | 0.1481 | MN20160310_N02 | M17 |
| MCF 10A-H2B-mCherry | Trametinib | 0.31623 | 48.36 | 17.25 | 997 | 4390 | 0.2271 | 0.6614 | MN20160310_N02 | M17 |
| MCF 10A-H2B-mCherry | Trametinib | 0.31623 | 50.33 | 17.25 | 817 | 4651 | 0.1757 | 0.6125 | MN20160310_N02 | D08 |
| MCF 10A-H2B-mCherry | Trametinib | 0.31623 | 50.33 | 17.25 | 872 | 4651 | 0.1875 | 0.6255 | MN20160310_N02 | D08 |
| MCF 10A-H2B-mCherry | Trametinib | 0.31623 | 50.33 | 17.25 | 50 | 4651 | 0.0108 | 0.1409 | MN20160310_N02 | M17 |
| MCF 10A-H2B-mCherry | Trametinib | 0.31623 | 50.33 | 17.25 | 1016 | 4651 | 0.2184 | 0.6566 | MN20160310_N02 | M17 |
| MCF 10A-H2B-mCherry | Trametinib | 0.31623 | 52.30 | 17.25 | 842 | 4798 | 0.1755 | 0.6142 | MN20160310_N02 | D08 |
| MCF 10A-H2B-mCherry | Trametinib | 0.31623 | 52.30 | 17.25 | 869 | 4798 | 0.1811 | 0.6205 | MN20160310_N02 | D08 |
| MCF 10A-H2B-mCherry | Trametinib | 0.31623 | 52.30 | 17.25 | 54 | 4798 | 0.0113 | 0.1509 | MN20160310_N02 | M17 |
| MCF 10A-H2B-mCherry | Trametinib | 0.31623 | 52.30 | 17.25 | 1034 | 4798 | 0.2155 | 0.6555 | MN20160310_N02 | M17 |
| MCF 10A-H2B-mCherry | Trametinib | 0.31623 | 54.27 | 17.25 | 860 | 4884 | 0.1761 | 0.6159 | MN20160310_N02 | D08 |
| MCF 10A-H2B-mCherry | Trametinib | 0.31623 | 54.27 | 17.25 | 880 | 4884 | 0.1802 | 0.6205 | MN20160310_N02 | D08 |
| MCF 10A-H2B-mCherry | Trametinib | 0.31623 | 54.27 | 17.25 | 54 | 4884 | 0.0111 | 0.1504 | MN20160310_N02 | M17 |
| MCF 10A-H2B-mCherry | Trametinib | 0.31623 | 54.27 | 17.25 | 979 | 4884 | 0.2005 | 0.6419 | MN20160310_N02 | M17 |
| MCF 10A-H2B-mCherry | Trametinib | 0.31623 | 56.24 | 17.25 | 860 | 4929 | 0.1745 | 0.6147 | MN20160310_N02 | D08 |
| MCF 10A-H2B-mCherry | Trametinib | 0.31623 | 56.24 | 17.25 | 880 | 4929 | 0.1785 | 0.6192 | MN20160310_N02 | D08 |
| MCF 10A-H2B-mCherry | Trametinib | 0.31623 | 56.24 | 17.25 | 54 | 4929 | 0.0110 | 0.1501 | MN20160310_N02 | M17 |
| MCF 10A-H2B-mCherry | Trametinib | 0.31623 | 56.24 | 17.25 | 1104 | 4929 | 0.2240 | 0.6649 | MN20160310_N02 | M17 |
| MCF 10A-H2B-mCherry | Trametinib | 0.31623 | 58.21 | 17.25 | 873 | 4942 | 0.1766 | 0.6173 | MN20160310_N02 | D08 |
| MCF 10A-H2B-mCherry | Trametinib | 0.31623 | 58.21 | 17.25 | 898 | 4942 | 0.1817 | 0.6229 | MN20160310_N02 | D08 |
| MCF 10A-H2B-mCherry | Trametinib | 0.31623 | 58.21 | 17.25 | 57 | 4942 | 0.0115 | 0.1577 | MN20160310_N02 | M17 |
| MCF 10A-H2B-mCherry | Trametinib | 0.31623 | 58.21 | 17.25 | 984 | 4942 | 0.1991 | 0.6412 | MN20160310_N02 | M17 |
| MCF 10A-H2B-mCherry | Trametinib | 0.31623 | 60.18 | 17.25 | 856 | 5031 | 0.1701 | 0.6110 | MN20160310_N02 | D08 |
| MCF 10A-H2B-mCherry | Trametinib | 0.31623 | 60.18 | 17.25 | 881 | 5031 | 0.1751 | 0.6166 | MN20160310_N02 | D08 |
| MCF 10A-H2B-mCherry | Trametinib | 0.31623 | 60.18 | 17.25 | 53 | 5031 | 0.0105 | 0.1469 | MN20160310_N02 | M17 |